ISPE Names Sanofi S.A. the 2026 ISPE Facility of the Year Awards (FOYA) Overall Winner for its Modulus Project

Sanofi S.A. has earned ISPE's top FOYA honor for excellence and innovation in pharmaceutical facility design and manufacturing.

NORTH BETHESDA, Md., Oct. 19, 2026 /PRNewswire/ -- The International Society for Pharmaceutical Engineering (ISPE) has recognized Sanofi S.A. as the FOYA Overall Winner of the 2026 ISPE Facility of the Year Awards (FOYA) for its Modulus project. FOYA honors outstanding achievement and innovation in pharmaceutical facility design, construction, and operation across multiple categories, with one project selected annually for the program's highest recognition.

The Overall Winner was announced during the ISPE FOYA Banquet and Awards Celebration. The event took place during the 2026 ISPE Annual Meeting & Expo in Washington, D.C., USA, the evening of 18 October. The event recognized this year's Category Winners and brought together industry leaders, project teams, and partners to celebrate excellence and innovation in pharmaceutical manufacturing. The announcement marked the culmination of the 2026 FOYA program.

"For more than two decades, the FOYA program has recognized projects that advance pharmaceutical manufacturing," said Parag Sane, Chair of the Facility of the Year Awards Judging Committee. "Sanofi's Modulus project stands out for its innovative approach to facility design, combining modular architecture, digital integration, and operational flexibility to support the evolving needs of vaccine and biologics production. It exemplifies the type of industry-leading innovation the FOYA program was created to celebrate."

Sanofi's Modulus project features twin manufacturing facilities in Neuville-sur-Saône, France, and Tuas, Singapore, designed to support flexible vaccine and biologics production. Built around a modular "plug-and-produce" architecture, the facilities incorporate adaptable production spaces, advanced automation, autonomous mobile robots, and digital twin technology, enabling rapid reconfiguration across multiple products and manufacturing platforms. The project applies a standardized facility design across two global sites and is designed to accommodate multiple products and manufacturing processes over the life of the facilities.

Prior to its FOYA Overall Winner recognition, Sanofi S.A.'s Modulus project was announced as a 2026 ISPE FOYA Submission Finalist at the 2026 ISPE Facilities of the Future Conference and as the 2026 ISPE FOYA Category Winner for Facility of the Future at the 2026 ISPE Europe Annual Conference earlier this year.

The call for submissions is now open for the 2027 FOYA program, ending Monday, 7 December. The 2027 ISPE FOYA Submission Finalists will be announced at the 2027 ISPE Facilities of the Future Conference, taking place 1–2 February 2027 in Long Beach, California, USA.

To learn more about FOYA, visit ISPE.org/FOYA.

About the ISPE FOYA Program
Established in 2005, the FOYA program recognizes state-of-the-art projects utilizing new, innovative technologies to improve the quality of products, reduce the cost of producing high-quality medicines, and demonstrate advances in project delivery. The FOYA program provides a platform for the pharmaceutical science and manufacturing industry to showcase its accomplishments in facility design, construction, and operation, while sharing the development of new applications of technology and cutting-edge approaches. Visit ISPE.org/FOYA for more information.

About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is a global nonprofit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 25,000+ members of ISPE provide solutions to complex pharmaceutical industry challenges through innovation, member and workforce development, and technical, regulatory, and compliance collaborations in more than 120 countries worldwide. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland, USA, and its operations center in Tampa, Florida, USA. For more information, visit ISPE.org.

SOURCE ISPE